We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Annonce boursière - Réservée aux médias et aux investisseurs - GSK mène à terme l'acquisition de BELLUS Santé Canada NewsWire LONDON, le 28 juin 2023...
Stock-exchange announcement - For media and investors only - GSK completes acquisition of BELLUS Health Canada NewsWire LONDON, June 28, 2023 LONDON, June 28, 2023 /CNW/ - GSK plc (LSE: GSK...
S&P Dow Jones Indices annonce des modifications à l'indice composé S&P/TSX et à l'indice S&P/TSX 60 Canada NewsWire TORONTO, le 2 sept. 2022 TORONTO, le 2 sept...
S&P Dow Jones Indices Announces Changes to the S&P/TSX Composite Index and S&P/TSX 60 Index Canada NewsWire TORONTO, Sept. 2, 2022 TORONTO, Sept. 2, 2022 /CNW/ - As a result of the...
BELLUS Santé inc. (Nasdaq : BLU; TSX : BLU) (« BELLUS Santé » ou la « société »), une société biopharmaceutique au stade clinique qui développe de nouveaux produits thérapeutiques pour le...
BELLUS Health Inc. (Nasdaq:BLU; TSX:BLU) (“BELLUS Health” or the “Company”), a clinical-stage biopharmaceutical company developing novel therapeutics for the treatment of refractory chronic cough...
BELLUS Health Inc. (Nasdaq:BLU; TSX:BLU) (“BELLUS Health” or the “Company”), a clinical-stage biopharmaceutical company developing novel therapeutics for the treatment of refractory chronic cough...
Period | Change | Change % | Open | High | Low | Avg. Daily Vol | VWAP | |
---|---|---|---|---|---|---|---|---|
1 | 0 | 0 | 19.48 | 19.48 | 19.48 | 0 | 0 | CS |
4 | 0 | 0 | 19.48 | 19.48 | 19.48 | 0 | 0 | CS |
12 | 0 | 0 | 19.48 | 19.48 | 19.48 | 0 | 0 | CS |
26 | 0 | 0 | 19.48 | 19.48 | 19.48 | 0 | 0 | CS |
52 | 0 | 0 | 19.48 | 19.48 | 19.48 | 0 | 0 | CS |
156 | 9.48 | 94.8 | 10 | 19.9 | 6.3 | 57439 | 12.29684298 | CS |
260 | 10.67 | 121.112372304 | 8.81 | 19.9 | 2.7 | 97718 | 8.61635142 | CS |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions